Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma

Inhibition of JAK1, 2/STAT3 Signaling Induces Apoptosis, Cell Cycle Arrest, and Reduces Tumor Cell Invasion in Colorectal Cancer Cells

(2015) Hua Xiong et al.   NEOPLASIA

The JAK-STAT Pathway at Twenty

(2012) George R. Stark et al.   IMMUNITY

Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma

(2012) Thomas Knösel et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Signal Transducer and Activator of Transcription 3 (STAT3) Protein Suppresses Adenoma-to-carcinoma Transition inApcmin/+Mice via Regulation of Snail-1 (SNAI) Protein Stability

(2012) Jongdae Lee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies

(2012) Pasquale Sansone et al.   JOURNAL OF CLINICAL ONCOLOGY

Therapeutic Targeting of the Interleukin-6 Receptor

(2011) Toshio Tanaka et al.   Annual Review of Pharmacology and Toxicology

STAT3 controls matrix metalloproteinase-1 expression in colon carcinoma cells by both direct and AP-1-mediated interaction with the MMP-1 promoter

(2011) Constance Zugowski et al.   BIOLOGICAL CHEMISTRY

DSC3 expression is regulated by p53 and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer

(2011) T Cui et al.   BRITISH JOURNAL OF CANCER

Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition

(2011) Hua Xiong et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma

(2011) Z. Hamidov et al.   JOURNAL OF CLINICAL PATHOLOGY

Loss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancer

(2010) Y Okugawa et al.   BRITISH JOURNAL OF CANCER

Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells

(2010) Chih-Ping Hsu et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer

(2010) J. A. D. Simpson et al.   GUT

Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trial

(2010) F. Monnien et al.   JOURNAL OF CLINICAL PATHOLOGY

Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma

(2009) S Takemoto et al.   BRITISH JOURNAL OF CANCER

Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease

(2009) Stefan Rose-John et al.   CURRENT PHARMACEUTICAL DESIGN

Stat3 Is a Negative Regulator of Intestinal Tumor Progression in ApcMin Mice

(2009) Monica Musteanu et al.   GASTROENTEROLOGY

pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation

(2009) Douglas A. Stewart et al.   LEUKEMIA & LYMPHOMA

Signaling Molecules: The Pathogenic Role of the IL-6/STAT-3 Trans Signaling Pathway in Intestinal Inflammation and in Colonic Cancer

(2008) R. Atreya et al.   CURRENT DRUG TARGETS

Ups and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling

(2008) Gabriella Regis et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

The role of signal transducers and activators of transcription in colon cancer

(2007) Lidija Klampfer   Frontiers in Bioscience-Landmark